Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C McArthur

Showing results (311-320 of 359) with videos related to

Pageof 36
Sort By:
AIDS (London, England)|May 3, 2014
Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapyTodd Hulgan, Rebecca T Levinson, Mariana Gerschenson, et al.
Archives of Neurology|May 12, 2010
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER StudyRonald J Ellis, Debralee Rosario, David B Clifford, et al.
Journal of Neurovirology|January 6, 2016
Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort studyEdward R Hammond, Rosa M Crum, Glenn J Treisman, et al.
American Journal of Epidemiology|June 27, 2014
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIVEdward R Hammond, Rosa M Crum, Glenn J Treisman, et al.
Archives of Neurology|November 10, 2004
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapyJustin C McArthur, Michael P McDermott, Daniel McClernon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2012
Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected personsAdriana S A Andrade, Reena Deutsch, Shivaun A Celano, et al.
Neurology|May 5, 2021
Large Mitochondrial DNA Deletions in HIV Sensory NeuropathyRicardo H Roda, David Bargiela, Weiran Chen, et al.
The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.
Neurology|December 15, 2004
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementiaJ J Sevigny, S M Albert, M P McDermott, et al.
Archives of Neurology|January 11, 2007
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infectionJeffrey J Sevigny, Steven M Albert, Michael P McDermott, et al.
Pageof 36

Showing results (311-320 of 359) with videos related to

Sort By:
Pageof 36
AIDS (London, England)|May 3, 2014
Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapyTodd Hulgan, Rebecca T Levinson, Mariana Gerschenson, et al.
Archives of Neurology|May 12, 2010
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER StudyRonald J Ellis, Debralee Rosario, David B Clifford, et al.
Journal of Neurovirology|January 6, 2016
Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort studyEdward R Hammond, Rosa M Crum, Glenn J Treisman, et al.
American Journal of Epidemiology|June 27, 2014
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIVEdward R Hammond, Rosa M Crum, Glenn J Treisman, et al.
Archives of Neurology|November 10, 2004
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapyJustin C McArthur, Michael P McDermott, Daniel McClernon, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2012
Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected personsAdriana S A Andrade, Reena Deutsch, Shivaun A Celano, et al.
Neurology|May 5, 2021
Large Mitochondrial DNA Deletions in HIV Sensory NeuropathyRicardo H Roda, David Bargiela, Weiran Chen, et al.
The Clinical Neuropsychologist|June 20, 2012
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratingsK Blackstone, D J Moore, D R Franklin, et al.
Neurology|December 15, 2004
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementiaJ J Sevigny, S M Albert, M P McDermott, et al.
Archives of Neurology|January 11, 2007
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infectionJeffrey J Sevigny, Steven M Albert, Michael P McDermott, et al.
Pageof 36